Pregnancy study for people exposed to nifurtimox
Part of Infections clinical trials.
This is an observational study that follows pregnant people who took nifurtimox during pregnancy. Researchers want to better understand the risk of pregnancy complications and check both mother’s and baby’s health over time.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must have taken at least one dose of nifurtimox at any time during your pregnancy.
- Your exposure can be from around conception (first day of last menstrual period) through delivery.
- You (or, if you’re a minor, you and a parent/guardian) must agree to join by signing consent paperwork.
- If you’re under the age of majority, you may need an assent form as well as parent/legal guardian consent.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new drug called LXE408 for people with chronic Chagas disease. It aims to see if the drug is safe and effective, and participants will also receive standard treatment with benznidazole.
This trial compares a shorter course of benznidazole (a medicine for Chagas disease) to the standard longer treatment. It aims to see if the shorter regimen works as well and is safe for people with confirmed Chagas infection.
This trial is testing new rapid diagnostic tests to detect infection with Trypanosoma cruzi, which causes Chagas disease. It aims to find faster ways to diagnose people who may be at risk, such as pregnant women, blood donors, or those with possible chronic infection.
This Phase 1 study tests how safe and tolerable chloroquine is when given alongside standard tuberculosis medicine. It mainly involves healthy volunteers and helps researchers understand side effects and safe dosing.
This study tests a nutrition and caregiving program for pregnant women and their babies in southwest Guatemala. It aims to see if starting the program during pregnancy leads to healthier growth and development in children up to age 2.
This study looks at what happens when ibrexafungerp is taken during pregnancy, including outcomes for the baby. You may join if you were exposed to this medicine during pregnancy (or very close to conception) and you agree to share information and complete study follow-up.
Hear when a new Chagas Disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.